XML 49 R38.htm IDEA: XBRL DOCUMENT
v3.24.3

Earnings Per Common Share (Tables) | 9 Months Ended
--- | ---
Sep. 28, 2024
Earnings Per Share [Abstract] |
Schedule of Earnings Per Share, Basic and Diluted | The following table provides the inputs to the calculations of basic and diluted earnings per common share (share amounts not in thousands):
| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | September 28, 2024 |  | September 30, 2023
Loss from continuing operations | $ | (32,598) |  |  | $ | (26,540) |  |  | $ | (25,995) |  |  | $ | (40,555) |
Income from discontinued operations | — |  |  | 1,440 |  |  | 3,217 |  |  | 312 |
Net loss available for common stockholders | $ | (32,598) |  |  | $ | (25,100) |  |  | $ | (22,778) |  |  | $ | (40,243) |
Weighted average shares used for determining basic earnings per share of common stock | 65,892,750 |  |  | 65,343,418 |  |  | 65,686,397 |  |  | 65,024,654 |
Dilutive effect of: |  |  |  |  |  |  |
Stock options | — |  |  | — |  |  | — |  |  | — |
Performance and restricted stock | — |  |  | — |  |  | — |  |  | — |
Weighted average shares used for determining diluted earnings per share of common stock | 65,892,750 |  |  | 65,343,418 |  |  | 65,686,397 |  |  | 65,024,654 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | Anti-dilutive instruments excluded from the computation of diluted earnings per share included (not in thousands):
| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | September 28, 2024 |  | September 30, 2023
Stock options | — |  |  | 46,798 |  |  | — |  |  | 46,798 |
Performance and restricted stock | 3,419,691 |  |  | 3,302,332 |  |  | 3,419,691 |  |  | 3,302,332 |
Total anti-dilutive instruments | 3,419,691 |  |  | 3,349,130 |  |  | 3,419,691 |  |  | 3,349,130 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration